[Ivabradine in the treatment of patients with angina pectoris: lessons of the BEAUTIFUL trial].
The article is devoted to results of additional analysis of a randomized, double-blind, placebo-controlled, parallel-group BEAUTIFUL trial. Effects of If inhibitor ivabradine in patients with ischemic heart disease, left ventricular dysfunction and stable angina were analyzed.
Lopatin
Iu M
IuM
D000787:Angina Pectoris / Q000188:drug therapy*; D001552:Benzazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D054815:Cyclic Nucleotide-Gated Cation Channels; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077550:Ivabradine; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D001552:Benzazepines; D054815:Cyclic Nucleotide-Gated Cation Channels; D000077550:Ivabradine